Pharmaceutical Technology on MSN

Vertanical’s VER-01 gains FDA breakthrough status for low back pain

VER-01 offers an investigational approach distinct from traditional treatment paradigms.

FDA Grants Breakthrough Therapy Designation to VERTANICAL's VER-01, a First-in-Class Non-Opioid Investigational Treatment for Chronic Low Back Pain

VERTANICAL today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to VER-01, the company's first-in-class non-opioid investigational treatment for ...
Hosted on MSN

Can a simple mental shift cure chronic back pain? New scientific study reveals breakthrough in pain relief

In a world saturated with prescriptions, surgeries, and temporary fixes for chronic back pain, a groundbreaking new study is challenging the status quo. Researchers from Australia are offering an ...